Name: Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases
Basic research, experimental diagnosis and medical care of hepatitis C; New strategies for immunotherapy for liver diseases.
Study of epidemiology and factors influencing the progression of HCV infection, optimizing treatment for difficult-to-treat hepatitis C.
Development of therapeutic vaccines against HCV and hepatocellular carcinoma. immunotherapy, DC-mediated immunotherapy for chronic hepatitis B.
Establishment of reference materials of HCV for experimental diagnosis.
Director: Wei Lai
Contact: Wang Jianghua
Address: Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Xizhimen South Street 11th, Xizhimen District, Beijing, 100044, P. R. China